GlassScriptPhysician profile
Nathaniel D Ho
NPI 1497792147
$3,967.93
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $1,836 · 2021: $510 · 2022: $680 · 2023: $298 · 2024: $20.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.84 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,485.68 | 2019-2022 | |
| Vifor Pharma, INC. | $405.29 | 2019-2023 | Veltassa, Korsuva |
| Astrazeneca Pharmaceuticals LP | $297.83 | 2019-2022 | |
| Akebia Therapeutics INC | $270.39 | 2019-2023 | Auryxia |
| Fresenius USA Marketing, INC. | $249.89 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $249.69 | 2019-2023 | Jynarque |
| Opko Pharmaceuticals, LLC | $212.00 | 2019-2023 | Rayaldee |
| Amgen INC. | $131.48 | 2019-2023 | Parsabiv |
| Calliditas Therapeutics US INC. | $118.58 | 2022-2023 | Tarpeyo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.15 | 2022 | |
| Mallinckrodt Hospital Products INC. | $108.21 | 2020-2022 | |
| Boston Scientific Corporation | $82.52 | 2021-2022 | |
| Aurinia Pharma U.S., INC. | $45.38 | 2021-2022 | |
| Glaxosmithkline, LLC. | $40.33 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $32.92 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $30.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.50 | 2024 | |
| Gilead Sciences, INC. | $20.50 | 2021 | |
| Genzyme Corporation | $19.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.